was read the article
array:22 [ "pii" => "S166526812400259X" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101465" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.78" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268124002606" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101466" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.79" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Effect of methyl donor supplementation on gut microbiota and hepatic expression of key miRNAs in a murine model of MAFLD" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rebeca Rosas-Campos, Ángel O. Vázquez-Esqueda, Marina Galicia-Moreno, Juan Armendáriz-Borunda, Ana S. Sandoval-Rodríguez" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Rebeca" "apellidos" => "Rosas-Campos" ] 1 => array:2 [ "nombre" => "Ángel O." "apellidos" => "Vázquez-Esqueda" ] 2 => array:2 [ "nombre" => "Marina" "apellidos" => "Galicia-Moreno" ] 3 => array:2 [ "nombre" => "Juan" "apellidos" => "Armendáriz-Borunda" ] 4 => array:2 [ "nombre" => "Ana S." "apellidos" => "Sandoval-Rodríguez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002606?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002606/v2_202404250742/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1665268124002588" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101464" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.77" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Acute liver failure secondary to co-infection of Hepatitis B and HIV" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Yajzeel Estevez-López, Alan J. Romero-Sanchez, José E. López-Ruiz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Yajzeel" "apellidos" => "Estevez-López" ] 1 => array:2 [ "nombre" => "Alan J." "apellidos" => "Romero-Sanchez" ] 2 => array:2 [ "nombre" => "José E." "apellidos" => "López-Ruiz" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002588?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002588/v2_202404250742/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "MexMix supplementation prevented MAFLD development by restoring microbiota-gut-liver axis in a mice model." "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Rebeca Rosas-Campos, Ana S. Sandoval-Rodríguez, Ángel O. Vázquez-Esqueda, Ricardo de la Rosa-Bibiano, Jonathan S. Rodríguez-Sanabria, Rebeca Escutia-Gutiérrez, Arturo Santos-García, Juan Armendáriz-Borunda" "autores" => array:8 [ 0 => array:3 [ "nombre" => "Rebeca" "apellidos" => "Rosas-Campos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 1 => array:3 [ "nombre" => "Ana S." "apellidos" => "Sandoval-Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 2 => array:3 [ "nombre" => "Ángel O." "apellidos" => "Vázquez-Esqueda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 3 => array:3 [ "nombre" => "Ricardo" "apellidos" => "de la Rosa-Bibiano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 4 => array:3 [ "nombre" => "Jonathan S." "apellidos" => "Rodríguez-Sanabria" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 5 => array:3 [ "nombre" => "Rebeca" "apellidos" => "Escutia-Gutiérrez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 6 => array:3 [ "nombre" => "Arturo" "apellidos" => "Santos-García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">2</span>" "identificador" => "aff0002" ] ] ] 7 => array:3 [ "nombre" => "Juan" "apellidos" => "Armendáriz-Borunda" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">2</span>" "identificador" => "aff0002" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Institute of Molecular Biology in Medicine, Health Sciences Center, University of Guadalajara, Guadalajara, Mexico" "etiqueta" => "1" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "School of Medicine and Health Sciences, Tecnologico de Monterrey, Guadalajara, Mexico" "etiqueta" => "2" "identificador" => "aff0002" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Ethical statement</span></p><p id="para0006" class="elsevierStylePara elsevierViewall">The protocol was registered and approved by the Ethics Committee.</p><p id="para0007" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Declaration of interests</span></p><p id="para0008" class="elsevierStylePara elsevierViewall">None</p><p id="para0009" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Funding</span></p><p id="para0010" class="elsevierStylePara elsevierViewall">None</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara001" class="elsevierStyleSimplePara elsevierViewall">The microbial communities’ control is crucial to maintaining homeostasis of gut-liver axis; clinical evidence demonstrates disruptions of microbiota-gut-liver in individuals with Metabolic-associated fatty liver disease (MAFLD). Foods rich in fiber and polyphenols have been associated with an improvement in microbiota diversity, indexand miRNAs expression. The aim of this study was to evaluate the effect of a supplementation with a mixture of Mexican foods (MexMix): Opuntia ficus indica (nopal), Theobroma cacao (cocoa) and Acheta domesticus (crickets) on gut-liver axis in a MAFLD mice model.</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Patients</span><p id="spara002" class="elsevierStyleSimplePara elsevierViewall">Thirty C57BL/6J mice were divided into three groups: 1) control: normal diet. 2) HF: high fat diet (60%) and fructose/sucrose water 3) MexMix: HF diet up to week 10, followed by HF diet supplemented with 6.7% nopal, 8.7% cocoa, and 8.7% cricket for 8 weeks.</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">The MexMix animals showed a significantly decreased in body weight, visceral and epididymal fat, adipocyte size, triglycerides, insulin, leptin, and PAI-1; while adiponectin levels increased. Using 16S rRNA gene sequencing, MexMix increased phylogenetic diversity, Firmicutes abundance, and enrichment of 10 beneficial genera, including <span class="elsevierStyleItalic">Lachnospiraceae, Ruminococcaceae, Akkermansia</span>, and <span class="elsevierStyleItalic">Eubacterium_coprostanoligenes_group</span>. In the gut, MexMix supplementation significantly increased SCFAs concentration, intestinal crypts depth, <span class="elsevierStyleItalic">Ocln</span> and <span class="elsevierStyleItalic">Cldn1</span> expression, and decreased <span class="elsevierStyleItalic">Il6</span> and <span class="elsevierStyleItalic">Tnf-a</span> expression. In liver, MexMix significantly reduced steatosis and Tnfa expression. Besides, MexMix increased nuclear translocation of NFR2 and, in consequence, a higher hepatic expression of <span class="elsevierStyleItalic">Cat</span> and <span class="elsevierStyleItalic">Sod</span>. MexMix also decreased hepatic expression of miRNA-34a, miRNA-103, and miRNA-33a.</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara004" class="elsevierStyleSimplePara elsevierViewall">Synchronous supplementation with three nutraceuticals, nopal, cacao, and cricket, produced better results compared to previous studies where foods were administered individually. MexMix demonstrated its efficacy as a prebiotic, promoting the growth of beneficial genera and improving intestinal health. These findings indicate that MexMix has the potential to serve as a therapeutic approach for treating MAFLD in patients, as well as other conditions associated with excessive consumption of fats and sugars.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Patients" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000029000000S2/v2_202404250742/S166526812400259X/v2_202404250742/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000029000000S2/v2_202404250742/S166526812400259X/v2_202404250742/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526812400259X?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 0 | 3 |
2024 October | 12 | 5 | 17 |
2024 September | 16 | 5 | 21 |
2024 August | 15 | 5 | 20 |
2024 July | 16 | 6 | 22 |
2024 June | 17 | 5 | 22 |
2024 May | 17 | 4 | 21 |
2024 April | 14 | 7 | 21 |
2024 March | 18 | 15 | 33 |